Results 131 to 140 of about 118,580 (161)

Quality of life after radio frequency ablation turbinate reduction (RFATR) among patients with rhinitis medicamentosa & withdrawal from decongestant topical spray abuse.

American Journal of Otolaryngology, 2023
OBJECTIVE Radiofrequency ablation (RFA) reliefs nasal obstruction and improves quality of life (QoL) in patients suffering from inferior turbinate hypertrophy (ITH). A substantial benefit was noted among patients suffering from Rhinitis Medicamentosa (RM)
N. N. Carmel Neiderman, Inbar Caspi, N. Eisenberg, Nir Halevy, Anat Wengier, Iris Shpigel, Tomer Ziv Baran, Barak Ringel, Anton Warshavsky, A. Abergel   +9 more
semanticscholar   +1 more source

Long‐term treatment outcomes in refractory rhinitis medicamentosa managed with nasal surgery

International Forum of Allergy and Rhinology, 2023
Limited treatment options exist for refractory Rhinitis Medicamentosa (RM). The role of surgery after failed medical management is not well defined. Mucosal contact points and restricted airflow often perpetuate decongestant use.
William Li, Shibalik Misra, R. Harvey, L. Kalish   +3 more
semanticscholar   +1 more source

Revisiting Rhinitis Medicamentosa: Examining the Evidence on Topical Nasal Decongestants

Journal of pharmacy and practice
Background: Over-the-counter topical nasal decongestants are effective and well-tolerated treatments for the temporary relief of nasal congestion, a symptom that can impair quality of life. Their duration of use is limited owing to potential for rhinitis
Martina Hagen, Gabor Varbiro, E. Montanari, Mariane Ballerini Fernandes   +3 more
semanticscholar   +1 more source

[Development of an experimental rabbit model of rhinitis medicamentosa].

Vestnik otorinolaringologii
BACKGROUND Rhinitis medicamentosa (RM), resulting from prolonged use of nasal decongestants, represents a significant clinical problem. The pathogenetic mechanisms of RM remain insufficiently studied, and existing methods for assessing the state of the ...
V. Svistushkin, K. Eremeeva, X. Yang, E. Smolyarchuk, A. Nedorubov, A. Machikhin, A. Guryleva, D. A. Derevesnikova, E. Kulikova   +8 more
semanticscholar   +1 more source

Determination of Oxidative Stress and Effect of Erdosteine on Rhinitis Medicamentosa in a Rat Model

European Journal of Pharmacology, 2014
We aimed to determine the presence of oxidative stress in rhinitis medicamentosa (RM) and to evaluate the effect of erdosteine (ED) on mucosal changes in a rat model. Twenty-four male rats were used in this experimental study.
Fatih Sefil, Recep Dokuyucu, Tümay Özgür   +2 more
exaly   +2 more sources

Outcomes after Functional Nasal Surgery in Patients with Versus without Rhinitis Medicamentosa

The Laryngoscope
Topical nasal decongestants (TNDs) are used to reduce nasal soft tissue edema and obstruction. However, after frequent TND use, patients can develop rhinitis medicamentosa (RM) with rebound nasal edema and obstruction.
Anthony P. Di Ponio, M. Samad, Richard Pellizzari, Hussein Mackie, Robert H. Deeb, J. Craig   +5 more
semanticscholar   +1 more source

Development of rhinitis medicamentosa in young chronic nasal drop users

Annals of Case Reports and Medical Images
Rhinitis Medicamentosa (RM), commonly known as rebound nasal congestion, is an increasingly prevalent condition among young individuals who chronically use topical nasal decongestants.
Arnabjyoti De
semanticscholar   +1 more source

[Rhinitis medicamentosa].

Vestnik otorinolaringologii, 2020
One type of non-allergic non-infectious rhinitis is represented by a heterogeneous group of rhinitis medicamentosa, which can be divided into several pathogenetic types.
O. Ostroumova, E. V. Shikh, E. Rebrova, A. Ryazanova   +3 more
semanticscholar   +1 more source

Investigation of cytotoxic effects of oxymetazoline on lung in a rat model of rhinitis medicamentosa.

Current Molecular Pharmacology, 2020
BACKGROUND Rhinitis medicamentosa, also known as 'rebound congestion,' is inflammation of the nasal mucosa caused by the overuse of topical nasal decongestants.
B. Cengiz, M. Bostancıklıoğlu, T. Demir, H. Karabulut, Recep Dokuyucu, M. Ulaşlı   +5 more
semanticscholar   +1 more source

Comparison of holmium laser turbinate reduction and partial turbinoplasty in the surgical treatment of rhinitis medicamentosa

Journal of Laryngology and Otology
Objectives Rhinitis medicamentosa is a challenging condition resulting from prolonged nasal decongestant use. This study aimed to compare holmium laser turbinate reduction and partial turbinoplasty surgical options.
Nurdoğan Ata, Mustafa Gulluev, Kayhan Öztürk   +2 more
semanticscholar   +1 more source